Publiée 2021-09-21
(c) Copyright The Planet 2018
Ce travail est disponible sous la licence Creative Commons Attribution 4.0 International .
Comment citer
Résumé
Background: Viral hepatitis is the most common cause of acute hepatitis. Viral hepatitis is caused by infection with any of at least five distinct viruses. Out of them, the three most commonly identified viruses in developing countries are Hepatitis A Virus (HAV), hepatitis B virus (HBV) and hepatitis E virus (HEV). Hepatitis A Virus and hepatitis E virus spread by faecooral route which are endemic in those area where sanitation is poor. Hepatitis B virus spreads by parenteral, sexual and vertical transmission. Materials and methods: This is a prospective study conducted in Medicine unit -II of Sher-eBangla Medical College Hospital, Barishal, Bangladesh over a period of six months (January '18 to June '18) among the patients of Acute Viral Hepatitis to find out the underlying aetiology, to see the patterns of presentation and risk factors. Result: Male (76.7%) and younger age group<30yrs (73.3%) constituted the bulk of the cases. Majority of the cases (81 %) came from low socioeconomic condition. Out of 120 patients of Acute Viral Hepatitis, 70% are caused by HEV, 23.3% by HBV and 6.7% by HAV.
Références
- Dible JH, Mc Michael J, Sherlock SPV. Pathology of acute hepatitis aspiration biopsy studies of epidemic arsenotherapy and serum jaundice. Lancet 2003; ii 402.
- Lemon SM.Type A viral hepatitis.New developments in an old disease. N. Engl. J.Med. 1995; 313(17): 1059-1067.
- Krugman S, Ward R, Giles JP. Infectious): hepatitis; detection of virus during the incubation period and in clinically inapparent infection. N. Engl. J.Med. 2009; 261(15):729- 734.
- Feinstone SM, Gust IA. Hepatitis A vaccine .In: Plotkin SA, Orenstein WA, editors. Vaccines.3rd ed. Philadelphia, PA; WB Squnders Company; 2013. P.650-671.
- Aggwarwal R, Naik SR. Epidemiology of hepatitis E past present and future. Top. Gastroenteral. 1997; 18: 19.
- Ankalle VA, Tsarev SA, Chandha MS et al. Age specific prevalances of antibodies to hepatitis A and E virus in Pune, India, 1982 and 1992. J.Infect. Dis. 1995; 171:447.
- Khurrom S, Kamili S, Jameel S, Vertical transmission REV.Lancet 1995;345; 1025-6. 8. Smedile A, Carci P, Verma G, Caredda F, Cargael A, Caporaso N et al.
- Arankalle VA, Chandra MS, Tsarev SA, Emerson SU, Banerjeek, Purchell RH. Seroepidemiology of water born hepatitis in India {; evidence for a third enterically transmitted hepatitis agent. Proc. Natt Acud SW, USA 1994; 91; 3428-3432.
- Dominguez A, Salleras L, Garmona G et al. Effectiveness of a mass hepatitis A vaccination program. In preadolescents. Vaccine 2003; 21:698-701.
- Szmunes SW, Stevens CE, Harley ET et al. Hepatitis B vaccine; demonstration of efficacy in a controlled trial in a high risk population in the United States. N. Engl. J.Med. 1980; 303:833.
- Coursaget P, Leboulleux D, Sourmare M et al. Twelve-years follow-up study of hepatitis B immunization of Senegalese infants. J.Hepatol.1994; 2 l: 250.
